Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study
- 18 December 2006
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 78 (7) , 699-701
Abstract
Background: High plasma concentrations of factor VIII (FVIII) and von Willebrand factor (VWF) have been recently associated with a moderately increased risk of venous thrombosis, but their roles in cerebral sinus and venous thrombosis (CSVT) have not been addressed. To determine whether elevation of FVIII and VWF is more frequent in CSVT, we analysed plasma levels of FVIII and VWF in a case control study. Methods: The study population consisted of 25 consecutive patients (of whom nine were excluded) admitted for CSVT to the Department of Neurology, Amiens University Hospital, France, from January 1997 to December 2002, for a general screening for thrombophilia. Sixty-four healthy subjects matched for age and sex formed the group control. Results: Mean FVIII (CSVT: 167.3 (SD 48.8) IU/dl; control group: 117.9 (39.8) IU/dl; p = 0.001) and VWF levels (CSVT: 165.4 (76.5)%; control group: 108.5 (27.8)%; p = 0.01) were significantly higher in the CSVT group. Using the 95th percentile of the control group as the cut off value, elevated FVIII (>190 IU/dl) occurred in 25% (4/16) (p = 0.005) and elevated VWF (>168%) in 37.5% (6/16) of patients with CSVT (p150 IU/dl or >150%) showed the same results (FVIII: p = 0.005; VWF: p = 0.009). Conclusion: Our study suggests that elevation of plasma factor VIII levels is the most common prothrombotic risk factor for CSVT. Elevation of VWF is also associated with an increased risk of CSVT but its effect seems to be partly mediated through FVIII.Keywords
This publication has 19 references indexed in Scilit:
- Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada – is it necessary to define a new upper reference range for factor VIII?Thrombosis and Haemostasis, 2005
- Endothelial Cell Markers and the Risk of Coronary Heart DiseaseCirculation, 2004
- Cerebral venous thrombosisNeurology, 2003
- Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)The American Journal of Medicine, 2002
- [Thrombophilias associated with cerebral venous thrombosis].2002
- Cerebral Vein and Dural Sinus Thrombosis in Portugal: 1980–1998Cerebrovascular Diseases, 2001
- Familial Clustering of High Factor VIII Levels in Patients With Venous ThromboembolismArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- High Plasma Levels of Factor VIII and the Risk of Recurrent Venous ThromboembolismNew England Journal of Medicine, 2000
- Elevation of FVIII: C in Venous Thromboembolism Is Persistent and Independent of the Acute Phase ResponseThrombosis and Haemostasis, 2000
- von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 1999